Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 25
2015 21
2016 9
2017 4
2018 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery.
Iqbal J, Kwok CS, Kontopantelis E, de Belder MA, Ludman PF, Giannoudi M, Gunning M, Zaman A, Mamas MA; British Cardiovascular Intervention Society (BCIS) and the National Institute for Cardiovascular Outcomes Research (NICOR). Iqbal J, et al. Circ Cardiovasc Interv. 2016 Apr;9(4):e003151. doi: 10.1161/CIRCINTERVENTIONS.115.003151. Circ Cardiovasc Interv. 2016. PMID: 27069103 Free article.
Prospective assessment of a palliative care tool to predict one-year mortality in patients with acute coronary syndrome.
Moretti C, Iqbal J, Murray S, Bertaina M, Parviz Y, Fenning S, Quadri G, Gunn J, D'Ascenzo F, Marra S, Moiraghi C, Riccardini F, Veglio F, Gaita F, Denvir M. Moretti C, et al. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):272-279. doi: 10.1177/2048872616633841. Epub 2016 Feb 15. Eur Heart J Acute Cardiovasc Care. 2017. PMID: 26880851
Clinical outcomes of "complete, partially complete, and incomplete" revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents.
Zhang YJ, Iqbal J, Xu B, Ye F, Zhang JJ, Bourantas CV, Pan DR, Tian NL, Kan J, Qian XS, Ding SQ, Li F, Zhang AP, Liu YQ, Muramatsu T, Onuma Y, Garcia-Garcia HM, Serruys PW, Chen SL. Zhang YJ, et al. EuroIntervention. 2016 Oct 10;12(8):e957-e963. doi: 10.4244/EIJY15M12_06. EuroIntervention. 2016. PMID: 26690316 Free article.
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial.
Iqbal J, Verheye S, Abizaid A, Ormiston J, de Vries T, Morrison L, Toyloy S, Fitzgerald P, Windecker S, Serruys PW. Iqbal J, et al. EuroIntervention. 2016 Dec 10;12(11):e1336-e1342. doi: 10.4244/EIJY15M10_04. EuroIntervention. 2016. PMID: 26465374 Free article. Clinical Trial.
52 results